1. Home
  2. English
  3. Healthcare


Covid-19: Covovax Approved for 12-17 Age Group

NEW DELHI, April 29: The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India’s (SII) Covid-19 vaccine Covovax for the 12-17 age group. “The government panel decided to include Covovax in India’s immunisation drive against Covid-19,” official sources said. This makes Covovax another option for vaccines for children between the ages […]

Covid-19: As China struggles with new variants, a new wave may hit the world

Virendra Pandit:   New Delhi: Amid a resurgence of Covid-19 infections in part of China, including its financial hub Shanghai, Pune-based Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday stated that “Made in India” vaccines provided enhanced protection against the pandemic than mRNA vaccines like those manufactured by global pharmaceutical giants like Pfizer and […]